Release of α-glutathione s-transferase (α-GST) and hepatocellular damage induced by Helicobacter pylori and eradication treatment

Current Drug Safety

Volumn 2, Issue 1, 2007, Pages 43-46

  Karahalil, Bensu ^a   Yaǧar, Seyhan ^b   Özin, Yasemin ^c  

^a GAZI UNIVERSITY   (Turkey)

^b ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c Turkey High Specialization Hospital   (Turkey)

Author keywords

Alkaline Phosphatase (AP); Chronic Liver Disease; Glutathione S transferase immunoassay; Helicobacter pylori; Liver Function Tests

Indexed keywords

ALANINE AMINOTRANSFERASE; AMOXICILLIN; ANTIBIOTIC AGENT; ASPARTATE AMINOTRANSFERASE; CLARITHROMYCIN; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE TRANSFERASE ALPHA; ORNIDAZOLE; PROTON PUMP INHIBITOR;

ADULT; AGED; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; ERADICATION THERAPY; FEMALE; GRAM NEGATIVE BACTERIUM; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEPATIC ENCEPHALOPATHY; HUMAN; HYPOTHESIS; LIVER CELL DAMAGE; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PEPTIC ULCER; PRIORITY JOURNAL; REVIEW; SENSITIVITY ANALYSIS; SPIRAL AND CURVED BACTERIA; TREATMENT DURATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ANTI-INFECTIVE AGENTS; ASPARTATE AMINOTRANSFERASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; GLUTATHIONE TRANSFERASE; HELICOBACTER INFECTIONS; HEPATOCYTES; HUMANS; ISOENZYMES; LIVER DISEASES; LIVER FUNCTION TESTS; MALE; MIDDLE AGED;

EID: 34248206821     PISSN: 15748863     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488607779315426     Document Type: Review

References (28)

1. Giudice GD, Covacci A, Telford JL, Montecucco C, Rappuoli. The design of vaccines against Helicobacter Pylori and their development. Ann Rev Immun 2001; 19: 523-563.
2. Hunt RH. Helicobacter pylori eradication: a critical appraisal and current concerns. Scand J Gastroenterol Suppl 1995; 210: 73-6.
3. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200-05.
4. Dumonceau JM. Short-term side effects during H. pylori eradication therapy. Acta Gastroenterol Belg 1998; 61: 348-9.
5. El-Omar EM. What is the optimal therapy for the eradication of Helicobacter pylori? Nature Clin Practice Gastroenterol Hepatol 2006; 3: 126-127.
6. Dore MP, Maragkoudakis E, Pironti A, et al. Twice a day quadruple therapy for eradication of Helicobacter Pylori in the elderly. Helicobacter 2006; 11: 52-55.
7. Duseja A, Sachdev A, Dhiman RK, et al. Helicobacter pylori and hepatic encephalopathy. Indian J Gastroenterol 2003; 22: S31-32.
8. Farinati F, De Bona M, Floreani A, et al. Helicobacter pylori and the liver: any relationship? Ital J Gastroenterol Hepatol 1998; 30: 124-8.
9. Eduardo G, Luca M, Federica B, et al. Liver iron accumulation in chronic hepatitis C patients without HFE mutations: relationships with histological damage, viral load and genotype and (alpha)-glutathione S-transferase levels. Eur J Gastr Hepatol 2001; 13: 1355-61.
10. Beckett GJ, Hayes JD. Glutathione S-transferases: biomedical applications. Adv Clin Chem 1993; 30: 282-380.
11. Beckett GJ, Dyson EH, Chapman BJ, et al. Plasma glutathione S-transferase measurement by radioimmunoassay: a sensitive index of hepatocellular damage in man. Clin Chim Acta 1985; 146: 11-9.
12. Dickson RC, Lauwers GY, Rosen CB, et al. The utility of noninvasive serologic markers in the management of early allograft rejection in liver transplantation recipients. Transplantation 1999; 68: 247-53.
13. Hunt RH. Helicobacter pylori eradication: a critical appraisal and current concerns. Scand J Gastroenterol Suppl 1995; 210: 73-6.
14. Nelson DR, Lim HL, Oliver D, et al. α-glutathione S-transferase as a marker of hepatocellular damage in chronic hepatitis C virus infection. Clin Chem 1995; 104: 193-8.
15. Duseja A, Sachdev A, Dhiman RK, et al. Helicobacter pylori and hepatic encephalopathy. Indian J Gastroenterol 2003; 2: S31-2.
16. Tian XF, Fan XG, Fu CY, et al. Experimental study on the pathological effect of Helicobacter pylori on liver tissues. Zhonghua Gan Zang Bing Za Zhi 2005; 13: 780-83.
17. Lampe JW, Chen C, Li S, et al. Modulation of human glutathione S-transferases by botanically defined vegetable diets. CEBP 2000; 9: 787-93.
18. Dajani LK, Paus E, Warren DJ. Development as a rapid and sensitive immunofluorometric assay for glutathione S-transferase A. Clin Chem 2001; 47: 867-73.
19. Coppola N, De Stefano G, Marrocco C, et al. Helicobacter sp. and liver diseases. Infez Med 2003; 1: 201-7.
20. Miyaji H, Ito S, Azuma T, et al. Effects of Helicobacter pylori eradication therapy on hyperammonaemia in patients with liver cirrhosis. Gut 1997; 40: 726-30.
21. Nandakumar R, Naik Amitabh S, Pandit B, et al. Effect of Helicobacter pylori eradication on serum ammonia levels in patients with chronic liver disease. Indiana J Gastroenterol 2003; 22: 221-23.
22. Arabaci M, Koseoǧlu T, Ustundag Y, et al. Effects of Helicobacter pylori and liver cirrhosis on gastric mucosal hexosamine concentrations. Turkish J Gastroenterol 2001; 12: 206-10.
23. Coppola N, De Stefano G, Marrocco C, et al. Helicobacter sp. and liver diseases. Infez Med. 2003; 1: 201-7.
24. Higuchi H, Adachi Y, Wada H, et al. Comparison of plasma (α-glutathione S-transferase concentrations during and after low-flow sevoflurane or isoflurane anaesthesia. Acta Anaesthesiol Scand 2001; 45: 1226-29.
25. Oijen AH, Verhulst ML, Roelofs HM, et al. Eradication of Helicobacter pylori restores glutathione S-transferase activity and glutathione levels in antral mucosa. Jpn J Cancer Res 2001; 92: 1329-34.
26. Clarke H, Egan DA, Heffernan M, et al. Alpha-glutathione s-transferase (alpha-GST) release, an early indicator of carbon tetrachloride hepatotoxicity in the rat. Hum Exp Toxicol 1997; 16: 154-57.
27. Shrimali L, Chadda VS, Singh VB, et al. Study of prevalence of H pylori in hepatic encephalopathy due to various liver diseases. J Indian Acad Clin Med 2001; 2: 195-197.
28. Suttner SW, Schmidt CC, Boldt J, et al. Low-flow desflurane and sevoflurane anesthesia minimally affect hepatic integrity and function in elderly patients. Anesth Analg. 2000; 91: 206-12.